This document discusses feeding guidelines for low birth weight infants. It addresses nutrient requirements, formula choices, feeding regimens and adjuncts. Key points include recommendations for protein, calcium, phosphorus, iron and other nutrient intakes. Early initiation of minimal enteral nutrition is recommended to stimulate gut development while avoiding delays that can increase infection risk and mucosal damage. Human milk is preferred where possible, with fortification to meet nutrient needs. Preterm formulas are an alternative, tailored to the physiological and biochemical needs of preterm infants.
Content from guidelines on human milk banking published in Indian Journal of Pediatrics and references from CDC guidelines.
Recently asked in DNB Pediatrics theory examination.
Trophic feeding, by dr Amal Ahmed Khalil ,Port Said University, mohamed osama hussein
Trophic feeding is the practice of feeding small volume of enteral feeds in order to stimulate the development of the immature gastrointestinal tract of the preterm infant. This practice has also been termed as minimal enteral nutrition (MEN).
Growth charts in Neonates- Preterm and termSujit Shrestha
Growth charts in Newborn, Preterm and term neonates. All historically used charts in NICU are discussed here.
Presented by Dr Sujit, in Sir Ganga Ram Hospital
Nutritional Management of Premature InfantsMCH-org-ua
International conference «Actual approaches to the extremely preterm babies: International experience and Ukrainian realities» (Kyiv, Ukraine, March 5-6, 2013)
This presentation is part of and education series to pediatric healthcare providers in Syria and it may be useful to all practitioners working in low resource settings.
Content from guidelines on human milk banking published in Indian Journal of Pediatrics and references from CDC guidelines.
Recently asked in DNB Pediatrics theory examination.
Trophic feeding, by dr Amal Ahmed Khalil ,Port Said University, mohamed osama hussein
Trophic feeding is the practice of feeding small volume of enteral feeds in order to stimulate the development of the immature gastrointestinal tract of the preterm infant. This practice has also been termed as minimal enteral nutrition (MEN).
Growth charts in Neonates- Preterm and termSujit Shrestha
Growth charts in Newborn, Preterm and term neonates. All historically used charts in NICU are discussed here.
Presented by Dr Sujit, in Sir Ganga Ram Hospital
Nutritional Management of Premature InfantsMCH-org-ua
International conference «Actual approaches to the extremely preterm babies: International experience and Ukrainian realities» (Kyiv, Ukraine, March 5-6, 2013)
This presentation is part of and education series to pediatric healthcare providers in Syria and it may be useful to all practitioners working in low resource settings.
Nutritional education and health education in Pediatric Priya Gill
Nutrition education is the process of teaching the science of nutrition to an individual or group. Health professionals have a different role in educating an individual in the clinic, community, or long-term health-care facility.
The human body cannot make protein from carbohydrate or fat. So, we must eat adequate protein everyday.
Protein intake of both quantity and quality, during the first 2 years of life has important effects on growth, neurodevelopment, and long-term health.
In early life, the diet of children and adolescents is characterized by a higher protein intake than recommended.
Professor André Marette of the Physiology and Endocrinology Department at the Laval University in Canada explains the impact on health markers: “Is yogurt associated with reduced cardio-metabolic risk factors in children?“. During this talk, he evaluated the role of yogurt as a nutrient-dense snack and its influence in reducing the risk of developing diabetes and obesity.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
2. Feeding the LBW Infant
Objectives :
• Nutrient requirement
• Formula choices
• Options for feeding regimens
• Adjuncts to feeding
3. “There is no finer
investment for any
community than putting milk
into babies”
- Winston Churchill (1943)
4. LBW Nutrition - Introduction
Improved survival of premies & LBWs
Greater morbidity in preterms
Increased risk of growth deficits and
developmental delay
Increased risk of later adult disease
Recent research, marked difference
between LBW versus term AGA nutrition
5. Goals of LBW Nutrition
Short term :
- Mimic intrauterine growth/composition
Long term :
- Optimize neurodevelopmental outcome
- Impact adult onset disease
Prevent neonatal morbidities :
- Improve feed tolerance
- Reduce NEC
- Minimize infection
6. Problems of Preterm
Physiological Handicaps :
• Poor co-ordination of sucking & swallowing (<33 wks)
• Weak Gag reflex (aspiration)
• Lax esophageal sphincter
• Small gastric capacity
• Gastroparesis & intestinal hypomotility
Biochemical handicaps :
• High energy & micronutrient requirement.
• Higher fluid requirement
• Increase need for proteins, minerals & vitamins
• Relative deficiency of bile acids & lactase
Saili A et al, J Neonatol July-Sept 2002
7. Current Feeding Practices : Problems
• Volume restriction
• Uncertainty about proper conc. of
nutrients
• Global undernutrition of LBWs
• Increased volume of feeds only after
weight plateus (inadequate growth).
• Consequences : ↓ no. of brain cells,
deficit in learning, behavior and memory
8. Glucose
• 6 to 10 mg/kg/min, higher than term.
• Higher brain to body ratio
• Avoid higher percentage (adiposity &
↑ Co2)
• Hypoglycemia redefined as < 45
mg/dl
9. Revised Recommended Protein
Intake for PT Infants
26-30 wks PCA 4.4 g/kg/d
30-36 wks PCA 3.6-4.0 g/kg/d
36-40 wks PCA 3.0-3.4 g/kg/d
(Rigo J,J Pediatr,2006)
positive protein balance requires at least
1.5 g/kg/day – Hay ww et al, Pediatr Neonatol. 2010
10.
11. Lipids
• Vital ingredient
• Provision of 40-50% calories in TPN
• LA & ALA
• Lack of AA & DHA
• 0.5 gm/kg/d to prevent EFA deficiency
Controversies :
• Additional LC PUFA to formula/TPN
• Supplemental DHA & AA
12. Role of LCPUFA
* Breast milk has adequate conc.
* Present formulae deficient
* Most important DHA & AA
* Major constituents of nerve cell membranes
* Key role in the structural development of
retinal, neural & synaptic membranes.
* Important for visual & neurodevelopment
13. LBW Nutrition – LCPUFAs
• 11 RCTs involving PTs
• Many reported beneficial effects on visual,
neural and developmental outcome.
• Some reports of negative effect on growth
• Cochrane Review, Simmer K, 2004
- Increased early rate of visual maturation
- No effect on growth
- No long term benefit
- Use of fish oil & borage oil in PTs
(Fewtrell MS et al, J Pediatr, 2004)
14. Ca & P Supplementation
• Two- third body mineral content acquired
in 3rd
trimester
• Fetal accretion rates 105 mg/kg/d and 70
mg/kg/d for Ca & P respectively
• PT born with low skeletal stores
• Very high requirement
• Human milk feeding alone-
- Hypophosphatemia
- Poor bone mineralization
- Elevated Alk. Phospatase
- May lead to # & slow growth
15. Ca & P Supplementation
Osteopenia of prematurity, commoner < 1000 g
Ca & P deficiency, rarely vitamin D deficiency
Ca & P accretion in utero equal to puberty
Rates of bone formation equal to adult
Ca absorption around 60% - 70%
(Hawthorne KM et al, Minerva Pediatr, 2004)
16. Ca & P Supplementation
• Recommended intakes –
• Ca : 200-220 mg/kg/d,
• P : 100-110mg/kg/d
• Ca : P ratio > 16 wks GA 1.8:1
• Supplementation with both essential
for postnatal bone mineralization.
• Supplement till 42-43 wks PNA
• Cochrane Review : No studies which met
selection criteria were identified
(Carl A Kuschel , 2009)
17. LBW Nutrition - Iron
• Total body iron low at birth
• Further decrease in iron, phlebotomy
losses / Epo
• Early iron deficiency – Late cognitive
effects
• Dose 2-4 mg/kg/d started between 2 wks
to 2 mo PNA
• 6 mg/kg/d for Epo / IDA
(Rao R et al, Semin Neonatol. Oct. 2001)
18. Zinc Supplementation
* Preterm HM has less conc. & LBW may be zinc
deficient
* Better weight gain
* May improve immune function
* Improves mental development & behaviour ?
(Lira PI et al, Eur J Clin Nutr, 1998)
Sazwal et al, Indian StudySazwal et al, Indian Study, Pediatr 2001, Pediatr 2001
- Decreased risk of death due to diarrhea- Decreased risk of death due to diarrhea
- Zinc deficiency more in SGA babies- Zinc deficiency more in SGA babies
Effect on growthEffect on growth
- Better weight & height gain- Better weight & height gain
- Dose : 2 mg/kg/d x 6 wks- Dose : 2 mg/kg/d x 6 wks
Islam MN et al. indian pediatr, 2010Islam MN et al. indian pediatr, 2010
19. Vit.A Supplementation
Regulates & promotes growth of many cells
Maintains integrity of respiratory epithelial tract
Important for visual pigment, human function and as
antioxidant.
1000 IU / kg/d for all VLBW
Theraupeutic use
↓ O2 requirement & BPD
↓ ROP
↓ Nosocomial sepsis
Dose : 5000 IU IM 3 times a wk x 4 wks.
Oral - 4000 IU/kg/d
( Darlow BA, Cochrane Review, 2002)
20. Vitamin E in LBW Nutrition
•Routine supplementation, ↑ses Hb marginally
•↓ risk of IVH,
•↓ risk of severe ROP
•RD for LBW - 0.7 IU/100 kcal + 1 IU/gm
PUFA
•Recommended 10 mg/d (Oral)
IM 20 mg/kg/d x 3 d
•Side effects : sepsis, NEC, thrombocytosis
((Brian LP, Cochrane Review, 2006)Brian LP, Cochrane Review, 2006)
21. Enteral feeding - Early Gut Development
• Int. mucosal development by IInd
trimester.
• Organize motility develops till 28-30
wks.
• Motility – rate limiting
• Poor esophageal motility – GER
• Gastric emptying slower
• Only 50% <28 wks. pass mec. within
3 d.
22. Maturation of oral feeding skills in LBW infants
GA Maturation of feeding skills Initial feeding
method
< 28 wks No proper sucking efforts
No propulsive motility in the gut
Intravenous fluid
28-31 wks Sucking bursts develop
No coordination between
suck/swallow and breathing
Oro-gastric (or naso-
gastric) tube feeding
with occasional
spoon/paladai feeding
32-34 wks Slightly mature sucking pattern
Coordination between breathing &
swallowing begins
Feeding by
spoon/paladai/cup
>34 wks Mature sucking pattern
More coordination between breathing
and swallowing
Breast feeding
23. Enteral feeding - issues
• what milk to feed
• what nutritional supplements
• how to feed
• how much and how frequently
• what support
• how to monitor
24. What to feed
• Nutritional sources for LBW infants
Human milk
Breastmilk substitutes
Locally prepared animal milks
26. Recommended dietary allowance in preterm VLBW
infants and the estimated intakes with
fortified/unfortified human milk
RDA
(Units/kg/d)
At daily intake of 180 ml/kg
Only expressed
Breast milk
EBM fortified
with lactodex-
HMF
(4g/100mL)
EBM fortified
with preterm
formula
(4g/100mL)
Energy (kcal)
Protein (g)
Carbohydrates (g)
Fat (g)
Calcium (mg)
Phosphorus (mg)
Vit. A (IU)
Vit. D (IU/d)
Vit.E (IU)
Vit B1 (mcg)
Vit B2 (mcg)
Bit. B6 (mcg)
Folic acid (mcg)
Zinc (mg)
105-130
305-4.0
10-14
5.4-7.2
210
110
90-270
400
>1.3
>48
>72
>42
39.6
>0.6
117
2.46
11.6
6.8
43.2
22.2
680
3.5
1.9
36.2
84.2
25.7
6
0.6
144
3.2
16.84
7.1
223
112
3308
903
6.3
79.4
156.2
115.7
150
0.96
153
3.4
15.58
9.06
103
52
980
40
3.6
231
564.2
221
36
0.96
27. Recommended and Actual Intake of
Various Nutrients
Nutrient P-RNI Intake from FHM
kg/d Mother’ milk
Energy (Kcal) 105-135 88-145 104-174
Sodium (mmol) 2.5-4.0 1.3-2.2 1.7-2.8
Zinc (µmol) 17.0 7.7-12.3 20.6-34.3
Vit. D (IU/d) 400 4.8-8.0 257-428
Proteins (g) 3-3.5 2.0-3.4 2.9-4.8
Calcium (mg) 160-240 36-60 144-240
Phosph. (mmol) 2.5-3.8 0.5-0.9 2.3-3.8
Iron (mg) 2.0-3.0 0.04-0.06 0.04-0.06
28. Human milk
• Mother’s own milk and donor milk
• Fore milk and hind milk
• Drip milk and expressed milk
Storage of human milk
HUMAN MILK SUPPLEMENTS
29. Prevents Infection
& Inflammation
sIgA, Lactoferrin,
Lysozyme,
Cytokines,
oligosaccharides
Promotes int.
adoptation
sIgA, Growth factor,
hormones,
oligosaccharides
Enhance function
poorly expressed
in the infants
Lipids, cytokines,
hormones
Promotes
establishment of
beneficial microbiota
sIgA, Lactoferrin, α-LA,
Oligosaccharides
Compensate for
immaturity of the
intestine
Neocleotides, PAF-
AH, cytokines
growth factors
Beneficial
effects of
bioactive
agents in
HM
30. Human milk supplementation
• Individual vitamins or minerals
— Vitamin A
— Vitamin D
— Vitamin K
— Iron
— Zinc
— Calcium and phosphorus
• Multivitamins
• Multicomponent fortifiers
31. Multicomponent Fortifier
• facilitate more rapid catch-up
growth
• May improve neurodevelopmental
outcomes.
• logistically difficult for infants
fed directly
McCormick FM et al, 2010
32. Fortified Breast Milk : Safety
• HM – sterile product
• EBM contamination at various points.
- Pumping
- Storage
- Transportation
- Addition of fortifier
- Setup & administration of feed
• Effect of iron content on bacterial growth
(Dalidowitz C, J Am Diet Asso, Oct, 2005)
34. ENTERAL FEEDING – Time of initiation
• Early Vs Delayed feeding
• Early feeding < 4 d
• Delayed > 5-7 d
• Feeds delayed to dec. NEC
• No evidence that delayed introduction
of progressive enteral feeds prevents
NEC (Morgan J et al , cochrane, 2011 )
35. Delayed Feeding : Consequences
• Fewer mucosal antibody cells.
• Reduction in the local immune response.
• Decreased enzyme levels.
• Damage to mucosal barriers.
• Increased susceptibility to infections.
• Morphologic injury.
• Decreased secretion of IgA.
• Bacterial overgrowth.
36. Minimal Enteral Nutrition
(MEN) Benefits
- Stimulates secretion of GI hormones
- Improved glucose tolerance
(enteroinsular axis)
- Stimulates motor activity
- Stimulation of bile flow & ↓ cholestasis
AIIMS- NICU protocols 2008
37. Minimal Enteral Nutrition (MEN)
•Dilute / full strength feeds < 10 to 15mL/Kg/day
or no enteral nutrient intake (water only)
•“Trophic” feedings
•↓ feed intolerance
•? ↓ NEC
•↓ hospital stay
Tyson JE, Cochrane Review, 2006,
38. * Can be started on ventilator and /or
receiving TPN
* In severe birth asphyxia, after 48-72
hours
* VLBW infants born with antenatal
diagnosis of altered umbilical arterial
blood flow delayed for 2 to 3 days.
MEN - essentials
39. Initiation of Enteral Feeding : Issues
NG V/s OG Feeding :
Nasogastric feeding
- Pulmonary compromise
- Higher A & B
Orogastric Feeding :
- Grooved palate
- Sialadenitis
No large RCTs available, insufficient
data
(Cochrane Review, 2006)
40. Initiation of Enteral Feeding : Issues
Feeding tube placement :
Size of feeding tube : Problems with larger
tube
• Nasal inflammation
• Throat irritation
• Pressure necrosis
• Pulmonary compromise
• GER
• Apnea & bradycardia
Use smaller feeding tubes
41. Initiation of Enteral Feeding : Issues
Intermittent Bolus Feed
Benefits :
- Promotes cyclical surge of gut
hormones
- Promotes gut development
Risk :
- Feeding intolerance
- Delayed gastric empty / intestinal
transit
- Difficult metabolic homeostasis
42. Initiation of Enteral Feeding : Issues
Continuous Feeding :
Benefits :
- Energy efficient
- Improved nutrient absorption
- Reduced feed intolerance
- Improved growth
Risk :
- Alters cyclical pattern of release of
hormones
- Potential to affect metabolic homeostasis
− ↑ GER
43. Continuous vs. intermittent feeding
• There is no difference in time to
achieve full feedings
(Premji SS et al, Cochrane,2008 )
44. Enteral feeding - interval
• ad libitum or demand/semi demand
Vs Scheduled
• Some evidence - earlier hospital
discharge
(McCormick FM, Cochrane, 2010 )
45. Feeding volumes and frequency
Birth
weight
(g)
Starting
volume
(ml/kg/d)
Volume
increment
each day
(ml/kg/d)
Maximum
volume
(ml/kg/d)
Frequency
of feeds
<1200 10-20 20 180 2 hrly
1200-
1600
60 30 180 2 hrly
>1600 60 30 150 3 hrly
46. Cup feeding versus Bottle / spoon
• cup fed more likely to be exclusively
breastfed at hospital discharge
• no difference at 3 / 6 mo
• one study feed by cup spent ten days
longer in hospital
• cannot recommend cup feeding.
Flint A et al , Cochrane , 2008
47. Initiation of Enteral Feeding : Issues
Enteral Feeding with Umbilical Lines :
• Fear of feeding problems & NEC
• A prospective, RCT of 60 PT infants
with low UAC – no feeding problems
• Monitor infants for signs of feeding
problems.
48. Breast Feeding LBW - Challenges
• Fortification of preterm HM
• Establishing a milk supply
• Maintaining milk supply
• Transition from gavages to
breast feed
• Incidence and duration of BF
• Barrier to BF in PT
49. Initiation of Breast Feeding : When ?
• Traditional Criteria :
• Physiologic stability
• Ability to tolerate bolus feeds
• GA > 34 wks & BW > 1500 g
• Behaviorally based criteria :
• Mother – Caregiver observations
• Infant sucks on pacifier / tube
• Makes rooting motions
• Has brief periods of active / quiet alert state
50. feeding intolerance
•Significant abdominal distension or
discoloration
•Signs of perforation
•Obvious blood in stool
•Gastric residuals 25% to 50% of interval
volume for 2 to 3 feedings
•Bilious gastric residual or emesis
•Significant apnea/bradycardia
•Significant cardiopulmonary instability
(The Vermont Oxford Network "Got Milk" focus group ,2003)
54. Oil Application / Massage
• Greater weight gain
• ? Greater length gain
• Better neurobehavior
• Better thermoregulation
(Ramji S et al, 2005; Modkar JA et al, 2005)
• Better skin barrier function
∀↓ sepsis (use of sunflower seed oil)
(Darmstadt GL et al, 2005)
55. Feed Intolerance : Oral Erythromycin
• Potent prokinetic activity
• Acts through motilin receptors
• Improves feed tolerance
• Cochrane review, 2008- not enough evidence
to show any benefit
• high-dose erythromycin probably justifiable
(Lam HS et al, Curr Opin Pediatr. 2011 Apr;23(2):156-60 )
56. Lactase Treated Feeds
• Last of the disaccharidases to develop in PT.
• first detectable in the fetal intestine by 10
weeks' gestation
• At 28 to 34 weeks, lactase activity is only ~30%
• often managed with soy protein, protein
hydrolysate, low lactose, or lactose-free formulas
• Lactase to hydrolyse lactose for promotion of
growth & feed intolerance.
• greater rate of weight gain and higher serum
albumin- indicative of improved nutritional status
(J Pediatr, Oct. 2002)
• Single RCT, no significant benefit.
(Ohlsson A et al, cochrane 2006),
57. Feed Intolerance : Adjuncts
• Enteral insulin - accelerates GI develop.
- stimulates intestinal activity
- increases lactate activity
Pilot study, Shulman RJ, 2002
Limitation : Historic controls, need RCT
• Enteral solution (like human amniotic fluid)
- Phase I trial, significant increase in milk
feeding.
- May be related to growth factors
(Barney CK et al, Adv Neo Care, April, 2006)
• Cisapride : RCT, Kohl M et al, Biol Neonate, 2005
- No benefit (only in ELBW)
- More vulnerable to side effects
• Metoclopramide : No role, adverse effects
58. Role of Glutamine
•Increased feed tolerance
•Decreased sepsis
•Decreased nosocomial infections
•Better short term outcome
•Dose – 0.3 gm/kg/d
Van Den Berg et al, Am J Clin Nutr, 2005
• No effect on mortality, serious
infection, gut complications or long term
development.Tubman TRJ et al, Cochrane Review,
2006
•may lead to significant improvements
in growth Korkmaz A, Turk J Pediatr. 2007
59. Role of Arginine
• RCT
• 152 PT infants
• L-arginine (1.5 mmol/kg/d)
• Significant decrease in all
stage of NEC
(Amin HJ et al, J Pediatr 2002)
60. Role of probiotics
• Two Meta-analyses
• reduced the risk of death due to
all causes
• Significant decrease in NEC
• No effect on sepsis
• No significant adverse effects
• strain specific
Szajewska H, Early Hum Dev. 2010
62. Antenatal corticosteroids –
Role in PT nutrition.• Early introduction of enteral feeding
• Enhanced intestinal motility, integrity
and growth
• Maturation of intestinal arginine
synthesis
• Shortened hospital stay
Wu G et al, J Nutr Biochem Aug. 2004.
63. Feeding of LBW : Poor Weight Gain
Diet Considerations :
• Incorrect calculations of actual
intakes
• Milk prepared incorrectly
• Volume intakes not advanced for
weight gain.
• Increased nutrient demands
• Feed intolerance
64. Feeding of LBW : Poor Weight Gain
Use of Human Milk Consideration :
• Greater vol. production than intake
(foremilk V/s hindmilk)
• Incorrect proportion of HMF
• Need for sodium supplementation
• Need for increased vol. or protein
supple.
65. Approximate Daily Weight Gain for Infants
Gestational age g/kg/d
24-28 wk 15-20
29-32 wk 17-21
33-36 wk 14-15
37-40 wk 7-9
Corrected age g/d
40 wk – 3 mo 30
3-6 mo 20
6-9 mo 15
9-12 mo 10
12-24mo 6
Care of high-risk infant, Klaus,2000
68. MCT oil for wt gain
• primarily of energy
• Increased weight-length ratio
• producing obesity
• RCT, PE Vs MCT oil’
• Significantly higher protein intake
• better growth
Brumberg HL et al, J Perinatol. 2010
69. Postdischarge Nutrition
• Often neglected
• Mostly only breast fed
• More attention beneficial
Important for :
Who can’t consume ad libitum quantities
Poor growth
Abnormal biochemical screen of nutritional
status
Important – monitor just before and at least one
month after discharge and consider
fortification
Lucas A et al, Pediatr 2001.
70. Weaning Preterm Infants
• Early onset of weaning
• Use of foods with higher energy and
protein
• Foods rich in iron and zinc
• Beneficial effect on length & iron
status
Marriott LD et al, Arch Dis Child Fetal Neonatal ed.
Nov. 2003
71. Feeding Options for PTs
During stable growth phase
First Choice : preterm human milk +
Lactodex – HMF (if affordable) + Fe
supplements from 2 wks.
OR
Preterm human milk + Ca/P +
multivitamins, Zinc + Fe supplement.
Second Choice : LBW formula milk +
multivitamins, Zinc + Fe supplements.
Third Choice : Undiluted cow’s milk +
mltivitamins, Zinc + Fe supplement.
72. Potentially Better Practices
• Monitoring of growth & nutrition
• Early initiation of enteral nutrition
• Consistent systematic advancement of feeds.
• Uniformity & clarity as to withholding feeds.
• HM is the preferred nutrient for PT
• Use of appropriate enteral products
• Early initiation of TPN, when feasible
(The Vermont Oxford Network "Got Milk" focus group ,2003)
74. Developmental signs that show readiness for feeding
Behaviour at
the breast
Response when
offered
expressed
breat mild by
cup
Range of
gestational or
post-menstrual
age (wks)
Feeding
readiness
Range of birth
weight
No definite
mouthing
No extrusion of
tongue, no
licking
< 28 No readiness
IV feeding
needed
Intragastric tube
may be possible
< 1000 g
75. Developmental signs that show readiness
for feeding
Behaviour at
the breast
Response when
offered
expressed
breast milk by
cup
Range of
gestational
or post-
menstrual
age (wks)
Feeding readiness Range of birth
weight
Occasional,
ineffective
suckling
attempts
Opning mouth,
tongue out of
the mouth,
licking milk.
Not able to
coordinate
breathing and
swallowing well
28-31 First signs of oral
readiness.
Intragastric feeding
appropriate Can try
small amount of
direct expression or
cup feeding to gain
oral experience
1000-1500g
76. Developmental signs that show readiness
for feeding
Behaviour at
the breast
Response when
offered
expressed breast
mild by cup
Range of
gestational
or post-
menstrual
age (wks)
Feeding readiness Range of birth
weight
May root and
attach to
breast. Weak
suckling
attempts
Opening mouth,
tongue forward,
licking milk
Able to
coordinate
breathing and
swallowing well
32-34 Can now use cup or
other alternative
feeding method for
most feeds.
Allow baby to
attach to breast for
part of feed or for
some feeds
1300-1800g
77. Developmental signs that show readiness
for feeding
Behaviour at
the breast
Response when
offered expressed
breast mild by cup
Range of
gestational or
post-
menstrual
age (wks)
Feeding
readiness
Range of birth
weight
Able to root
and attach to
the breast
May have
periods of
organized
suckling with
long pauses
Opening mouth,
tongue forward,
licking milk,
coordinating
breasting and
swallowing
Coordinating
breathing and
swallowing well
An now able to
suck at the milk
from the cup and
other alternatives
33-35 Breast feed for
part of feedor
some complete
feeds
Cup or
alternative
supplement
most feeds to
ensure
adequate intake
1600-2000g
78. Developmental signs that show readiness
for feeding
Behaviour at
the breast
Response when
offered expressed
breast mild by cup
Range of
gestational or
post-
menstrual
age (wks)
Feeding
readiness
Range of birth
weight
Able to suckle
effectively at
the breast
Able to suck at milk
from the cup and
other alternative
feeding methods
34-36 Breastfeed, and
may need some
supplements by
cup or other
alternative
1800-2200g